Insider Buying: Neonc Technologies (NASDAQ:NTHI) President Buys 6,000 Shares of Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Amir Heshmatpour acquired 6,000 shares of the company’s stock in a transaction on Monday, November 24th. The shares were bought at an average price of $6.51 per share, with a total value of $39,060.00. Following the completion of the purchase, the president directly owned 2,992,000 shares of the company’s stock, valued at approximately $19,477,920. This represents a 0.20% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Neonc Technologies Stock Performance

Shares of Neonc Technologies stock traded up $1.46 during trading on Monday, reaching $7.32. The company’s stock had a trading volume of 88,158 shares, compared to its average volume of 126,910. Neonc Technologies Holdings, Inc. has a one year low of $3.20 and a one year high of $25.00. The stock has a 50-day moving average price of $10.04 and a two-hundred day moving average price of $7.45.

Neonc Technologies (NASDAQ:NTHI) last released its earnings results on Friday, November 14th. The company reported ($0.45) earnings per share (EPS) for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e)” rating on shares of Neonc Technologies in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Neonc Technologies has a consensus rating of “Sell”.

Hedge Funds Weigh In On Neonc Technologies

A number of institutional investors have recently modified their holdings of the business. LVW Advisors LLC bought a new stake in shares of Neonc Technologies during the second quarter worth $108,000. Westmount Partners LLC lifted its stake in shares of Neonc Technologies by 333.7% in the second quarter. Westmount Partners LLC now owns 73,246 shares of the company’s stock worth $261,000 after acquiring an additional 56,358 shares during the period. HCR Wealth Advisors bought a new stake in shares of Neonc Technologies in the 2nd quarter valued at $54,000. SLT Holdings LLC bought a new stake in Neonc Technologies during the third quarter valued at $100,000. Finally, Global Retirement Partners LLC acquired a new stake in Neonc Technologies during the third quarter worth approximately $434,000.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.